BLAU (BLAU3) Main Indicators
Basic Data - BLAU3
| Company | BLAU |
| Corporate Name | BLAU FARMACÊUTICA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | A Companhia dedica-se à fabricação. comercialização. pesquisa e desenvolvimento de medicamentos de alta complexidade. |
| Share | BLAU3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 13.98 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 2.38 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
| Updated 09/19/2024 | |
Relative Prices - BLAU3
| Price/Earnings | 11.62 |
| Price/SBV | 1.23 |
| Price/Net Sales | 1.59 |
| Price/CFO | 10.56 |
| Price/FCF | 20.04 |
| Price/Total Assets | 0.81 |
| Price/EBIT | 8.02 |
| Price/Working Capital | 2.24 |
| Price/NCAV | 37.66 |
| EV/EBIT | 9.74 |
| EV/EBITDA | 8.42 |
| EV/Net Sales | 1.94 |
| EV/CFO | 12.83 |
| EV/FCF | 24.35 |
| EV/Total Assets | 0.98 |
| Company Market Cap | R$ 2.51 B |
| Enterprise Value | R$ 3.05 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 13.98 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 2.00% |
| Updated 09/19/2024 | |
Income Statement - BLAU3
| Net Revenue | R$ 1.57 B |
| Gross Result | R$ 520.57 M |
| EBIT | R$ 312.83 M |
| Depreciation and Amortization | - R$ 48.98 M |
| EBITDA | R$ 361.81 M |
| Net Profit | R$ 215.89 M |
| Net Profit/Share | R$ 1.20 |
| Updated 08/26/2024 | |
| Net Revenue | R$ 465.10 M |
| Gross Result | R$ 169.63 M |
| EBIT | R$ 72.08 M |
| Depreciation and Amortization | - R$ 12.83 M |
| EBITDA | R$ 84.90 M |
| Net Profit | R$ 48.73 M |
| Profit/Share | R$ 0.27 |
| Updated 08/26/2024 | |
Price and Volume Behavior - BLAU3
| Lowest Price 52 weeks | R$ 9.27 |
| Highest Price 52 weeks | R$ 16.89 |
| Variation 2024 | -7.41% |
| Variation 1 year | -13.81% |
| Variation 2 years(total) | -51.71% |
| Variation 2 years(yearly) | -30.41% |
| Variation 3 years(total) | -68.35% |
| Variation 3 years(yearly) | -31.80% |
| Variation 4 years(total) | - |
| Variation 4 years(yearly) | - |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 3.41 M |
| Updated 09/19/2024 | |
Returns and Margins - BLAU3
| Return on Initial Tangible Capital | 11.30% |
| Return on Initial Invested Capital | 10.22% |
| Pre-Tax Return on Initial Tangible Capital | 17.12% |
| Pre-Tax Return on Initial Invested Capital | 15.49% |
| Return on Initial Shareholder´s Equity | 11.52% |
| Return on Initial Asset | 8.64% |
| Gross Margin | 33.05% |
| Net Margin | 13.71% |
| EBIT Margin | 19.86% |
| EBITDA Margin | 22.97% |
| Initial Asset Turnover | 0.63 |
| Financial Leverage | 1.52 |
| Liabilities/Net Worth | 0.52 |
| Net Debt/EBITDA | 1.49 |
| Updated 08/26/2024 | |
Balance Sheet - BLAU3
| Cash and Cash Equivalents | R$ 20.42 M |
| Total Assets | R$ 3.10 B |
| Short-Term Debt | R$ 75.55 M |
| Long-Term Debt | R$ 484.84 M |
| Gross Debt | R$ 560.39 M |
| Net Debt | R$ 539.97 M |
| Shareholder´s Equity | R$ 2.04 B |
| Share Book Value | R$ 11.39 |
| Common Shares | 179,393,939 |
| Preferred Shares | 0 |
| Total | 179,393,939 |
| Common Shares in Treasury | 1,713,200 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 1,713,200 |
| Common Shares (Except Treasury) | 177,680,739 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 177,680,739 |
| Updated 08/26/2024 | |
Cash Flow - BLAU3
| Operating Cash Flow | R$ 237.57 M |
| Cash Flow from Investments | - R$ 491.72 M |
| Financing Cash Flow | R$ 177.07 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 77.08 M |
| Updated 08/26/2024 | |
| Operating Cash Flow | R$ 80.85 M |
| Cash Flow from Investments | - R$ 2.07 M |
| Financing Cash Flow | - R$ 84.84 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 6.07 M |
| Updated 08/26/2024 | |
Experimental - BLAU3
| CAPEX 3 months | - R$ 24.47 M |
| Free Cash Flow 3 months | R$ 56.38 M |
| CAPEX 12 months | - R$ 112.40 M |
| Free Cash Flow 12 months | R$ 125.17 M |
| Updated 08/26/2024 | |